Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.
<h4>Objectives</h4>We carried out a meta-analysis focusing on the relationship between length of AIB1 gene poly-Q repeat domain as a modifier of breast cancer (BC) susceptibility in patients with BRCA1 and BRCA2 mutation carriers.<h4>Data sources</h4>We searched MEDLINE and E...
Guardado en:
Autores principales: | Aida Bianco, Barbara Quaresima, Claudia Pileggi, Maria Concetta Faniello, Carlo De Lorenzo, Francesco Costanzo, Maria Pavia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec65cd31914f4a16ab242c491e560042 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017) -
Telomere length shows no association with BRCA1 and BRCA2 mutation status.
por: Emma Killick, et al.
Publicado: (2014) -
Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
por: Martin J Larsen, et al.
Publicado: (2013) -
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Juliette Coignard, et al.
Publicado: (2021) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021)